Clinical Trial Update: A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes [Phase 2]

View source ↗

Summary

Phase 2 cardiac safety study evaluating an investigational drug in people with Parkinson's disease experiencing motor fluctuations during

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Parkinson's Disease, Off Episodes of Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-10